Last reviewed · How we verify

Migraine Relief — Competitive Intelligence Brief

Migraine Relief (Migraine Relief) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Neurology.

marketed Trigeminal nerve Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Migraine Relief (Migraine Relief) — Theranica. Migraine Relief is a wearable neuromodulation device that delivers electrical stimulation to the trigeminal nerve to prevent or treat migraine headaches.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Migraine Relief TARGET Migraine Relief Theranica marketed Trigeminal nerve

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Migraine Relief — Competitive Intelligence Brief. https://druglandscape.com/ci/migraine-relief. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing